Along with collagen levels in your skin decreasing as you age, structural changes occur within the cartilage throughout your body
Worked example: 10 mg vial with 2 mL water Concentration: 10 mg divided by 2 mL = 5 mg/mL For a 2.5 mg dose: 2.5 divided by 5 = 0.50 mL = 50 units For a 5 mg dose: 5 divided by 5 = 1.0 mL = 100 units For a 7.5 mg dose: 7.5 divided by 5 = 1.5 mL = 150 units (requires a larger syringe or two draws) Worked example: 30 mg vial with 3 mL water Concentration: 30 mg divided by 3 mL = 10 mg/mL For a 2.5 mg dose: 2.5 divided by 10 = 0.25 mL = 25 units For a 5 mg dose: 5 divided by 10 = 0.50 mL = 50 units For a 10 mg dose: 10 divided by 10 = 1.0 mL = 100 units For a 15 mg dose: 15 divided by 10 = 1.5 mL = 150 units Notice how the 10 mg/mL concentration makes the math cleanest
The title for Figure 4 should be reconsidered as the term "mutually opposite signal modulation" is unclear and/or does not reflect the description to follow. Response: We have replaced the term mutually opposite signal modulation with: amplification of MC3R signaling and attenuation of GHSR1a signaling For Figure 5, the figure legend should clarified if 5-HT2c-GHSR1a dimerization produces reduced Ca++ accumulation with (as appears to be implied by the figure) or without ligand for each receptor. Response: To make it clearer that the 5-HT2C ligand is not required, while the ghrelin ligand is, we have changed the description to read: When dimerized with 5-HT2C, GHSR1a displays a 65% reduction in ghrelin-induced Ca2+ accumulation, with this effect not requiring the presence of a 5-HT2C ligand. Reviewer #2: The review includes an excellent explanation of GSHR1a dimerization with other receptors at the cellular and molecular level and also does a good job of explaining technical aspects of this type of work
One or more of three potential pathways may be involved: these are deposition of the drug per se or a metabolite thereof, stimulation of melanin production, and bacterial metabolism of the drug, alone or in combination [5]
New evidence suggests trizepatide (Zepound/Mounjaro) produces the largest weight loss on average, outperforming semaglutide in trials
